WHIPgroup has filed a patent infringement lawsuit on behalf of its client RegenLab USA LLC in the Southern District of New York, Case No. 17-cv-03845 (S.D.N.Y.) (filed May 22, 2017). RegenLab is a leading innovator of medical and pharmaceutical products that it distributes under the world-famous REGENLAB® brand. RegenLab developed a new and extremely effective way to enhance platelet rich plasma production that is patented in U.S. Pat. No. 8,529,957 (“the ‘957 patent”). The complaint alleges that Raj Kanodia, M.D., Garden City Dermatology, P.C., and Trifecta Health Medical P.C. infringe the ‘957 patent with their commercial promotion, use, and sale of a product called “Eclipse PRP.”
Under U.S. law, anyone who uses a system that is likely to have been made by a patented process, and who does not demonstrate that the system was not made by the patented process, is [Read More…]
Recently, WHIPGROUP engaged in an arbitration that included a five day hearing in the City. Here are some thoughts about why arbitration is different (not clearly better or worse) than litigation. Venue The AAA arbitral [Read More…]
WHIPGroup previously filed a Motion to Dismiss a patent infringement suit filed against its client TomTom in the Western District of Texas. Rather than opposing WHIPGroup’s motion to dismiss, Plaintiff MDSP Technologies LLC voluntarily dismissed [Read More…]